Search research articles
Contact Us
Filters
Showing results (131-140 of 153) with videos related to
Page
of 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 13, 2015
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
Anneleen Blykers, Steve Schoonooghe, Catarina Xavier, et al.
Molecular Cancer Therapeutics
|
May 2, 2022
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model
Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, et al.
Oncoimmunology
|
August 1, 2025
Immune modulation following α and β<sup>-</sup> radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model
Hannelore Ceuppens, Kirsten De Ridder, Thomas Ertveldt, et al.
Molecular Cancer Therapeutics
|
October 20, 2021
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy
Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 19, 2016
Development and Validation of a Small Single-domain Antibody That Effectively Inhibits Matrix Metalloproteinase 8
Delphine Demeestere, Eline Dejonckheere, Sophie Steeland, et al.
Molecular Therapy. Methods & Clinical Development
|
September 6, 2021
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade
Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 2017
Evaluation of Antiatherogenic Properties of Ezetimibe Using <sup>3</sup>H-Labeled Low-Density-Lipoprotein Cholesterol and <sup>99m</sup>Tc-cAbVCAM1-5 SPECT in ApoE<sup>-/-</sup> Mice Fed the Paigen Diet
Laurent S Dumas, François Briand, Romain Clerc, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 19, 2019
Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors
Evangelia Bolli, Matthias D'Huyvetter, Aleksandar Murgaski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 10, 2015
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 20, 2023
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)
Odrade Gondry, Catarina Xavier, Laurens Raes, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 153) with videos related to
Sort By:
Page
of 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 13, 2015
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
Anneleen Blykers, Steve Schoonooghe, Catarina Xavier, et al.
Molecular Cancer Therapeutics
|
May 2, 2022
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model
Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, et al.
Oncoimmunology
|
August 1, 2025
Immune modulation following α and β<sup>-</sup> radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model
Hannelore Ceuppens, Kirsten De Ridder, Thomas Ertveldt, et al.
Molecular Cancer Therapeutics
|
October 20, 2021
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy
Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 19, 2016
Development and Validation of a Small Single-domain Antibody That Effectively Inhibits Matrix Metalloproteinase 8
Delphine Demeestere, Eline Dejonckheere, Sophie Steeland, et al.
Molecular Therapy. Methods & Clinical Development
|
September 6, 2021
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade
Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 2017
Evaluation of Antiatherogenic Properties of Ezetimibe Using <sup>3</sup>H-Labeled Low-Density-Lipoprotein Cholesterol and <sup>99m</sup>Tc-cAbVCAM1-5 SPECT in ApoE<sup>-/-</sup> Mice Fed the Paigen Diet
Laurent S Dumas, François Briand, Romain Clerc, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 19, 2019
Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors
Evangelia Bolli, Matthias D'Huyvetter, Aleksandar Murgaski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 10, 2015
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 20, 2023
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)
Odrade Gondry, Catarina Xavier, Laurens Raes, et al.
Page
of 16